Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

Thank You!

Your message has been sent.

Oops, message not sent.

Please make sure fields are complete.

News

Testing Atezolizumab in Patients With Newly Diagnosed, Unresectable, or Metastatic Clear Cell Sarcoma or Chondrosarcoma


Study Description Go to Brief Summary: This phase II trial studies how well atezolizumab works in treating patients with chondrosarcoma or clear cell sarcoma that is newly diagnosed, cannot be removed by surgery (unresectable), or has spread to…

Read Article

Last Notice: Registration for Virtual Dialogue: This Coming Tuesday, September 14 at 7:30PM EST


Last Notice Chondrosarcoma CS Foundation, Inc. Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) This Event is Free to…

Read Article

Steppin’ for a Cause!


The Chondrosarcoma Foundation is hosting its first fundraising event to bring awareness to Chondrosarcoma: a rare bone and soft tissue cancer. Where: The comfort of your own neighborhood! When: anytime between October 3rd-9th …

Read Article

Chondrosarcoma Foundation Hosts it’s first Fund Raising Event


https://www.eventbrite.com/e/steppin-for-a-cause-tickets-166736518415

Read Article

Christian Meyer, M.D.; Ph.D. Bone and Soft Tissue Sarcoma Expert Rounds the Panel for the Virtual Dialogue on September 14


The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma Survivors and prominent experts to examine new technologies, medications, and clinical trials, as well as providing…

Read Article

Case Study on a Patient with Metastatic Conventional Chondrosarcoma Showing Positive Results


Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist For more information: Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human…

Read Article

Bone Cancer Research Trust publishes 15 year Progress Report on Bone Cancer Research


Did you know… Research initiated by the Bone Cancer Research Trust discovered that navigation guided surgery improves 5-year chondrosarcoma-specific survival from 53% to 76%! Read about this life-saving breakthrough and many more in our new…

Read Article

David Bowles, Ph.D., Author, Psychologist and CS Survivor will address Taking Charge of Your Care on September 14


Chondrosarcoma CS Foundation, Inc.Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) Join Us for This Very Informative…

Read Article

Contact Information


If you would like to learn more about CS Foundation or if you would like to learn more about the resources we provide to patients, families, caregivers, and physicians, please contact us by phone or send us a message.

**A Registered 501c3 Non-Profit Charity Organization. All donations are tax-deductible.**

Send a Message